Skip to main content

Find Clinical Trials

Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Study to Evaluate an Influenza Vaccine Candidate

NCT00321373

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Helsinki, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Kotka, Finland

View all 17 locations

View Trial Details

Completed

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children

NCT00383123

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Antioch, California, United States

GSK Investigational Site Fairfield, California, United States

GSK Investigational Site Fresno, California, United States

GSK Investigational Site Pleasanton, California, United States

View all 40 locations

View Trial Details

Completed

Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538213

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years

NCT01153685

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Sherbrooke, Quebec, Canada

View Trial Details

Completed

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00363077

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

NCT00753272

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Alabaster, Alabama, United States

GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Mobile, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

View all 274 locations

View Trial Details

Completed

Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

NCT00633074

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Saku, Estonia

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Elverum, Norway

GSK Investigational Site Hamar, Norway

GSK Investigational Site Paradis, Norway

GSK Investigational Site Stavanger, Norway

View Trial Details

Completed

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538473

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tartu, Estonia

GSK Investigational Site Caen, France

GSK Investigational Site Gières, France

GSK Investigational Site Lagord, France

View all 46 locations

View Trial Details